Page last updated: 2024-09-03

jolkinolide b and Carcinoma, Non-Small Cell Lung

jolkinolide b has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, X; Han, H	1

Other Studies

1 other study(ies) available for jolkinolide b and Carcinoma, Non-Small Cell Lung

Article	Year
Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells. Journal of cellular biochemistry, 2018, Volume: 119, Issue:6 Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Diterpenes; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycolysis; Hexokinase; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases	2018

Article

Year

Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.

Journal of cellular biochemistry, 2018, Volume: 119, Issue:6

Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Diterpenes; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycolysis; Hexokinase; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2018